Open Government Portal

Found 10 records similar to Exceptional importation and sale of drugs in relation to COVID-19: Overview

Federal

There is an unprecedented demand and urgent need for access to biocides during the COVID-19 pandemic. On March 1, 2021, the Minister of Health signed Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in relation to COVID-19. The interim order (IO) allows certain biocides that may not fully meet regulatory requirements to be imported and sold in Canada.

Last Updated: Apr. 30, 2021
Date Published: Mar. 1, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, Exceptional importation and sale, biocides, demand and urgent need for access, Minister of Health, Interim Order No. 2, regulatory requirements
Federal

The COVID-19 pandemic has created an urgent need for drugs, biocides, medical devices and foods for a special dietary purpose, and affected their supply in Canada. To help prevent or alleviate shortages of these products, the Minister of Health has signed an interim order (IO).

Last Updated: Apr. 30, 2021
Date Published: Mar. 1, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, Interim Order, exceptional importation and sale, prevent shortages
Federal

There is an unprecedented demand and urgent need for access to drugs during the COVID-19 pandemic. On March 30, 2020, the Minister of Health signed the Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in relation to COVID-19. The interim order (IO) allows certain drugs that may not fully meet regulatory requirements to be imported and sold in Canada.

Last Updated: May 1, 2020
Date Published: Apr. 6, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19 pandemic, Interim Order, Special dietary purpose, exceptional importation and sale of drugs.
Federal

the Minister of Health signed the Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19. An IO is one of the fastest mechanisms available to address large-scale public health emergencies, without following the usual regulatory processes.

Last Updated: Jul. 27, 2021
Date Published: Mar. 1, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, exceptional importation, sale of medical devices, Interim Order, extends and modifies certain measures, large-scale public health emergencies, regulatory processes
Federal

There is an unprecedented demand and urgent need for access to medical devices during the COVID-19 pandemic. On March 30, 2020, the Minister of Health signed the Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in relation to COVID-19. The interim order (IO) allows certain medical devices that may not fully meet regulatory requirements to be imported and sold.

Last Updated: May 1, 2020
Date Published: Apr. 17, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19 pandemic, medical device, exceptional importation and sale of medical devices, Interim Order, regulatory requirements on imported and sold medical devices.
Federal

This guidance document supports Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19 (Interim Order No. 2).

Last Updated: Apr. 30, 2021
Date Published: Mar. 17, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, guidance, reporting medical device shortages
Federal

The Interim Order (IO) No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential COVID-19 drugs and medical devices.

Last Updated: May 28, 2021
Date Published: May 3, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, Interim Order No. 2, Clinical Trials, Medical Devices and Drugs Relating
Federal

This interim order (IO) provides more tools for urgently addressing drug shortages related to COVID-19.

Last Updated: Apr. 30, 2021
Date Published: Oct. 16, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, Interim Order, prevention and alleviation of shortages of drugs, drug shortages related to COVID-19
Federal

The guidance documents contain information for applicants seeking authorization to conduct COVID-19 drug and medical device clinical trials under Interim Order (IO) No. 2.

Last Updated: May 28, 2021
Date Published: May 3, 2021
Organization: Health Canada
Formats: HTML
Keywords:  guidance document, Interim Order, IO No.2, coronavirus, COVID-19, clinical trials, drug, medical device, clinical trial authorization
Federal

Interim Order No. 2 Respecting Drugs, Medical Devices, and Foods for a Special Dietary Purpose in Relation to COVID-19 (Interim Order No. 2) was signed on March 1, 2021.

Last Updated: Apr. 30, 2021
Date Published: Mar. 25, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, Interim Order No. 2, Drugs, Medical Devices and Foods, a Special Dietary
Date modified: